DIA 2022 Global Annual Meeting

June 19-23, 2022 | Chicago, US

We are pleased to announce that we will be joining DIA 2022 Global Annual Meeting as exhibitors and delegates.  

The DIA 2022 Global Annual Meeting brings industry, regulators, academics, and patients together to co-create, problem-solve, and discuss global and local challenges facing professionals in the life sciences community. We are excited to be part of such an essential meeting for catalyzing knowledge creation and sharing to accelerate healthcare product development 

Come and meet us at booth #2546 and meeting space #1414!

Events
Published on:
May 19, 2022
Our delegates

Harry Barnett

Executive Vice President, Clinical, Alira Health
Damien Joseph

Damien Joseph

Commercial Product Associate, Self Care Catalysts, An Alira Health Company

Grace Almendra – Castillo

SVP, Digital Consumer Health, Alira Health

Kameka West

Manager, Regulatory Affairs, Alira Health

Jacob Tessier

Team Lead Medical Informatics, Self Care Catalysts, An Alira Health Company

Kelly Mehrer

Commercial Officer, Solutions Architect, Self Care Catalysts, An Alira Health Company
Laura Sailor

Laura Sailor

BD Director Pharma & Biotech, Alira Health
Leora Sazant

Leora Sazant

Associate Director, Operations, Self Care Catalysts, An Alira Health Company
Nicole Jardine

Nicole Jardine

Associate Manager, Patient Journey Analytics, Self Care Catalysts, An Alira Health Company
Ram Soyao

Ram Soyao

Senior Product Manager, Self Care Catalysts, An Alira Health Company

Renee Willmon

Senior Director, Evidence & Outcomes, Self Care Catalysts, An Alira Health Company
Scott Hull

Scott Hull

Senior Director, Decentralized Clinical Study/RWE Digital Strategy and Analytics, Self Care Catalysts, An Alira Health Company

Shameni Selvarajah

Associate Manager, Scientific Evidence, Self Care Catalysts, An Alira Health Company

Paolo Morelli

Jennifer Peters

Jennifer Peters

Manager, Clinical Development, Alira Health

Related news

Blog June 6, 2023
Content of Integrated Summaries of Efficacy and Safety (ISE/ISS): A Blog Series
Content of Integrated Summaries of Efficacy and Safety (ISE/ISS) blogs outline what elements are required for successful FDA submissions.
Biometrics ISE/ISS
Blog May 30, 2023
Specific Requirements for Integrated Summaries of Efficacy and Safety in FDA Submissions
This article in our Content of Integrated Summaries of Efficacy and Safety series focuses on specific requirements for FDA submissions.
Biometrics ISE/ISS
Publications May 25, 2023
The EU Pharmaceutical Package: Introduction to Changes
Alira Health’s Regulatory experts explore how the proposed package will disrupt the European regulatory landscape and what it means for companies.
EU Pharma Regulatory
Blog May 19, 2023
Content of the Integrated Summaries of Efficacy and Safety
This article in our Content of ISE/ISS series focuses on what elements are required in the ISE/ISS to ensure a successful submission.
Biometrics ISE/ISS
Blog May 11, 2023
Introduction to Integrated Summaries of Efficacy and Safety
This article in our ISE ISS series focuses on the structure of the common technical document (CTD) and the objectives of the ISE/ISS.
Biometrics ISE/ISS
News May 2, 2023
Alira Health Announces the Spin-Off of Product Development Laboratory
Alira Health, a global healthcare advisory, clinical research and technology company, announces the spin-off of ProDevLabs, a new company led by Dr. Mitchell Sanders, PhD, a former(...)
Drug Development Life Sciences Product Development
News February 23, 2023
Silicon Valley Bank Leads Group of Sponsors Funding LabCentral Ignite Programs to Support Underrepresented Life Sciences Entrepreneurs
Silicon Valley Bank has assembled a diverse group of organizations, including Wilson Sonsini Goodrich & Rosati, EisnerAmper, and Alira Health, to sponsor LabCentral Ignite, a first-and-only-of-its-kind(...)
Biotech Diversity Life Sciences
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.